Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Compass Therapeutics shares held by insiders are locked up until Oct. 12, 2025, to prevent market disruption.
Shares of Compass Therapeutics, Inc. held by company officers, directors, and certain affiliated shareholders are subject to a lock-up agreement ending October 12, 2025.
The 61-day restriction, which began August 12, prohibits selling, offering, pledging, transferring, or publicly announcing plans to dispose of common stock, options, warrants, or convertible securities without prior written consent from Jefferies LLC.
The rule applies to shares held directly or beneficially and is designed to prevent market disruption following a public offering.
Specific exceptions exist but are not detailed.
3 Articles
Las acciones de Compass Therapeutics en manos de personas internas están bloqueadas hasta el 12 de octubre de 2025, para evitar la disrupción del mercado.